Outlook and opportunities for engineered environments of breast cancer dormancy.

ABSTRACT: Dormant, disseminated breast cancer cells resist treatment and may relapse into malignant metastases after decades of quiescence. Identifying how and why these dormant breast cancer cells are triggered into outgrowth is a key unsolved step in treating latent, metastatic breast cancer. However, our understanding of breast cancer dormancy in vivo is limited by technical challenges and ethical concerns with triggering the activation of dormant breast cancer. In vitro models avoid many of these challenges by simulating breast cancer dormancy and activation in well-controlled, bench-top conditions, creating opportunities for fundamental insights into breast cancer biology that complement what can be achieved through animal and clinical studies. In this review, we address clinical and preclinica

SUBMITTER: Richbourg NR 

PROVIDER: S-EPMC10923521 | biostudies-literature | 2024 Mar

REPOSITORIES: biostudies-literature